SLN (STOCKS)
Silence Therapeutics Plc American Depository Share
$7.000000
+0.310000 (+4.63%)
Prev close: $6.690000
Company Information
- Exchange
- XNAS
- Sector
- Commercial Services
- Industry
- Miscellaneous Commercial Services
- CEO
- Iain Gladstone Ross
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $329.70M
- Employees
- 116
- P/E (TTM)
- -4.40
- P/B (TTM)
- 6.40
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Dec 2024 (Q4)
|
$0.21 | $0.00 | +0.0000 | +0.00% |
|
Dec 2023 (Q4)
|
$-0.37 | $0.00 | +0.0000 | +0.00% |
Financial Statements
| Revenues | $839.00K |
| Benefits Costs and Expenses | $75.87M |
| Cost Of Revenue | $172.00K |
| Costs And Expenses | $75.87M |
| Gross Profit | $667.00K |
| Operating Expenses | $79.07M |
| Research and Development | $56.06M |
| Other Operating Expenses | $23.01M |
| Operating Income/Loss | -$78.41M |
| Income/Loss From Continuing Operations After Tax | -$75.04M |
| Income/Loss From Continuing Operations Before Tax | -$75.03M |
| Income Tax Expense/Benefit | $11.00K |
| Net Income/Loss | -$75.04M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$75.04M |
| Net Income/Loss Available To Common Stockholders, Basic | -$75.04M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$0.54 |
| Diluted Earnings Per Share | -$0.54 |
| Basic Average Shares | 425,102,881 |
| Diluted Average Shares | 425,102,881 |
| Assets | $115.12M |
| Current Assets | $102.85M |
| Cash | $70.10M |
| Other Current Assets | $32.75M |
| Noncurrent Assets | $12.27M |
| Fixed Assets | $1.40M |
| Other Non-current Assets | $10.88M |
| Liabilities | $65.72M |
| Current Liabilities | $10.46M |
| Noncurrent Liabilities | $55.26M |
| Equity | $49.40M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $49.40M |
| Liabilities And Equity | $115.12M |
| Net Cash Flow From Operating Activities | -$65.57M |
| Net Cash Flow From Operating Activities, Continuing | -$65.57M |
| Net Cash Flow From Investing Activities | $6.39M |
| Net Cash Flow From Investing Activities, Continuing | $6.39M |
| Net Cash Flow From Financing Activities | $5.62M |
| Net Cash Flow From Financing Activities, Continuing | $5.60M |
| Exchange Gains/Losses | -$54.00K |
| Net Cash Flow | -$53.59M |
| Net Cash Flow, Continuing | -$53.54M |
| Comprehensive Income/Loss | -$77.00M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$70.32M |
| Other Comprehensive Income/Loss | $4.72M |